The invention provides a
bispecific antibody targeting CD3 and
MICA and an application of the
bispecific antibody. The present invention relates to a conjugate comprising: a first
antigen binding region comprising an anti-CD3
antibody or an
antigen binding fragment thereof; the present invention relates to an anti-CD3
antibody or an
antigen-binding fragment thereof, comprising a first antigen-binding region having
MICA binding activity, a second antigen-binding region having
MICA binding activity, the anti-CD3
antibody or the antigen-binding fragment thereof comprising a first
heavy chain variable region having a specific CDRs
amino acid sequence and a
first light chain variable region. The
bispecific antibody disclosed by the invention can be combined with CD3 and MICA so as to promote
T cell activation, secrete
cell factors and effectively promote PBMC (
peripheral blood mononuclear cells) to kill
tumor cells, so that the bispecific antibody has good anti-
cancer activity; moreover, the bispecific antibody has reduced
proinflammatory cytokine secretion promotion performance and
T cell activation promotion performance, is higher in safety, and has good clinical application value and
drug development value.